Overview

A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin

Status:
Completed
Trial end date:
2021-12-03
Target enrollment:
Participant gender:
Summary
AB-106-C111 is China-only study, for investigating the drug interaction between AB-106 and P-gp substrate (Digoxin). （n=16）
Phase:
Phase 1
Details
Lead Sponsor:
AnHeart Therapeutics Inc.
Treatments:
Digoxin